© 2004 by Oxford University Press
© 2004 Oxford University Press
NEWS |
Awards, Appointments, Announcements
The American Society for Clinical Oncology (ASCO) introduced several
new changes to its leadership at its annual meeting in June: David H. Johnson, M.D., deputy director of the Vanderbilt-Ingram Cancer Center in Nashville, Tenn., was named president. Sandra J. Horning, M.D., professor of medicine in the divisions of medical oncology and blood and marrow transplantation at Stanford University, will succeed him as president-elect.
The five new members of the ASCO Board of Directors are: S. Gail Eckhardt, M.D., professor of medicine at the University of Colorado Health Sciences Center in Denver; Peter D. Eisenberg, M.D., a community oncologist in private practice in California; Bruce D. Minsky, M.D., vice chair of radiation oncology at Memorial Sloan-Kettering Cancer Center in New York; Hyman B. Muss, M.D., professor of medicine at the University of Vermont in Burlington; and Nagahiro Saijo, M.D., Ph.D., director of the medical oncology division of the National Cancer Center Hospital in Tokyo.
David Ward, Ph.D., has been appointed deputy director of the
Nevada Cancer Institute in Las Vegas and will coordinate the institute's
efforts in basic research and population science. Ward, a member of the
National Academy of Sciences, was previously at Yale University, where he
served for more than 30 years as a professor in the department of genetics,
molecular biophysics, and biochemistry.
Brian E. Henderson, M.D., has been named dean of the Keck
School of Medicine of the University of Southern California in Los Angeles.
Henderson holds the Kenneth T. Norris Jr. Chair in Cancer Prevention.
Henderson replaced Stephen J. Ryan, M.D., who has resigned after 13 years as dean of the Keck School. He is returning to ophthalmology as president of the USC-affiliated Doheny Eye Institute and as the Grace and Emery Beardsley Chair in Ophthalmology at the Keck School.
The International Genetics Epidemiology Society has given its
Leadership Award to Christopher I. Amos, Ph.D., a professor of
epidemiology at the University of Texas M. D. Anderson Cancer Center in
Houston. The award recognizes his contributions to the field of genetic
epidemiology and his past service as president of the society.
The American Society for Therapeutic Radiology and Oncology (ASTRO)
has named three Gold Medal winners for 2004. They will receive their awards
October 4 at ASTRO's annual meeting.
Eli J. Glatstein, M.D., professor and vice chairman in the department of radiation oncology at the University of Pennsylvania Medical Center in Philadelphia, is being honored for his work in improving how physicians stage cancer, particularly Hodgkin disease.
Luka Milas, M.D., Ph.D., is being honored for his work in the basic biology of tumors and clinical applications. Milas is a professor of experimental radiation oncology and deputy head for translational research in the division of radiation oncology at the University of Texas M. D. Anderson Cancer Center in Houston.
Paul Wallner, D.O., chief of the clinical radiation oncology branch in the division of cancer treatment and diagnosis at the National Cancer Institute, is being given this award for his contributions to policy making and his service in the sociopolitical and economic arenas.
Bernard Fisher, M.D., has received the C. Chester Stock Award
from the Memorial Sloan-Kettering Cancer Center in New York for
"distinguished achievement in biomedical research." Fisher, a
distinguished service professor in the department of surgery at the University
of Pittsburgh and scientific director of the National Surgical Adjuvant Breast
and Bowel Project, published studies that showed that treatment with
lumpectomy, radiation therapy, and tamoxifen can replace mastectomy in breast
cancer patients.
Mary J. C. Hendrix, Ph.D., has joined the Robert H. Lurie
Comprehensive Cancer Center of Northwestern University in Chicago, where she
will also serve as president and scientific director of Children's Memorial
Hospital's research institute and professor of pediatrics at Northwestern's
School of Medicine. Hendrix comes to Northwestern from the University of Iowa
in Iowa City, where she headed the department of anatomy and cell biology and
served as deputy director of the Holden Comprehensive Cancer Center.
The American Society of Gene Therapy has presented its 2004 Young
Investigator of the Year Award to Laurence Cooper, M.D., Ph.D., for his
work in developing a new approach to improving the treatment of leukemia and
lymphoma. Cooper is a physician in the department of pediatric
hematology/oncology and an assistant professor in the division of molecular
medicine at the City of Hope Cancer Center in Los Angeles.
Items in "Awards, Appointments, Announcements" are compiled from notices received by the News section. Not all notices are used; all are edited.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||